Satellos Bioscience Inc. (MSLE)
NASDAQ: MSLE · Real-Time Price · USD
9.60
+0.13 (1.32%)
Aug 25, 2026, 1:30 PM EDT - Market open
Satellos Bioscience Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 7.39 | 9.8 | 40.07 | 16.71 | 1.42 | 3.85 |
Short-Term Investments | 54.45 | 17.91 | 8.48 | 13.27 | - | - |
Cash & Short-Term Investments | 61.84 | 27.71 | 48.55 | 29.98 | 1.42 | 3.85 |
Cash Growth | 61.81% | -42.92% | 61.96% | 2008.62% | -63.07% | 583.57% |
Other Receivables | 0.78 | 0.37 | 0.44 | 0.44 | 0.19 | 0.42 |
Receivables | 0.78 | 0.37 | 0.44 | 0.44 | 0.19 | 0.42 |
Prepaid Expenses | 0.64 | 0.19 | 0.18 | 0.11 | 0.03 | 0.03 |
Other Current Assets | 2.5 | 3.62 | 1.58 | 0 | 0 | - |
Total Current Assets | 65.76 | 31.88 | 50.74 | 30.53 | 1.65 | 4.3 |
Property, Plant & Equipment | 0.01 | 0.01 | 0 | 0.01 | 0.01 | 0.01 |
Long-Term Investments | - | - | - | 0.03 | 0.03 | - |
Other Intangible Assets | - | - | - | 2.97 | 2.89 | 5.64 |
Total Assets | 65.77 | 31.89 | 50.75 | 33.54 | 4.58 | 9.95 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.67 | 1.77 | 2.06 | 0.79 | 1.08 | 0.89 |
Accrued Expenses | 4.16 | - | - | 1.96 | 1.01 | 0.77 |
Current Income Taxes Payable | 0.03 | 0.07 | - | - | - | - |
Other Current Liabilities | - | 2.26 | 1.52 | - | - | - |
Total Current Liabilities | 5.86 | 4.11 | 3.58 | 2.74 | 2.09 | 1.66 |
Total Liabilities | 5.86 | 4.11 | 3.58 | 2.74 | 2.09 | 1.66 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 133.95 | 85.83 | 78.13 | 46.88 | 22.32 | 22.38 |
Additional Paid-In Capital | 11.78 | 10.17 | 7.9 | 6.44 | 2.72 | 0.98 |
Retained Earnings | -103.46 | -81.97 | -57.1 | -35.97 | -23.36 | -16.03 |
Comprehensive Income & Other | 17.63 | 13.76 | 18.23 | 13.45 | 0.8 | 0.97 |
Shareholders' Equity | 59.91 | 27.78 | 47.16 | 30.8 | 2.49 | 8.28 |
Total Liabilities & Equity | 65.77 | 31.89 | 50.75 | 33.54 | 4.58 | 9.95 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash (Debt) | 61.84 | 27.71 | 48.55 | 29.98 | 1.42 | 3.85 |
Net Cash Growth | 61.81% | -42.92% | 61.96% | 2008.62% | -63.07% | - |
Net Cash Per Share | 3.56 | 1.90 | 5.08 | 4.16 | 0.48 | 1.92 |
Filing Date Shares Outstanding | 21.22 | 20.83 | 13.82 | 9.4 | 3.48 | 2.75 |
Total Common Shares Outstanding | 20.84 | 15.46 | 13.82 | 9.4 | 3.48 | 2.75 |
Working Capital | 59.9 | 27.78 | 47.16 | 27.79 | -0.44 | 2.64 |
Book Value Per Share | 2.87 | 1.80 | 3.41 | 3.28 | 0.71 | 3.01 |
Tangible Book Value | 59.91 | 27.78 | 47.16 | 27.83 | -0.4 | 2.64 |
Tangible Book Value Per Share | 2.87 | 1.80 | 3.41 | 2.96 | -0.12 | 0.96 |
Machinery | - | - | - | - | 0.01 | 0.01 |